BDX logo

BDX Stock Overview

Profile

Full Name:

Becton, Dickinson and Company

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

United States

IPO:

February 21, 1973

Indexes:

S&P 500

Website:

http://www.bd.com

Description:

Becton, Dickinson and Company is an international company headquartered in Franklin Lakes, New Jersey, engaged in the development, manufacturing, and sale of a wide range of medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It was founded in 1897. The BD Medical segment produces a wide range of medical products used to help patients. The BD Life Sciences segment provides products for safe collection and transportation of diagnostic samples, as well as tools and reagent systems for detecting a wide range of infectious diseases. The BD Interventional segment offers cardiology, urology, oncology, and surgical disposable products.

Key Details

Price

$228.00

Market Cap

$65.47 B(Large cap)

Last Dividend

$1.04

TTM Dividend Yield

1.71%

Annual Revenue

$20.18 B(+4.16% YoY)

Annual EPS

$5.86(+18.62% YoY)

PE Ratio

37.87

Annual ROE

6.60%

Annual Debt To Equity

0.78

Beta

0.22

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Nov 7, 2024
Dividend

Next ex-dividend date:

Mar 10, 2025

Recent ex-dividend date:

Dec 9, 2024
Splits

Next split:

N/A

Recent split:

Apr 1, 2022

Analyst ratings

Recent major analysts updates

Feb 14, 25 Barclays
Overweight
Jan 28, 25 Piper Sandler
Overweight
Oct 1, 24 Evercore ISI Group
Outperform
Oct 1, 24 Citigroup
Buy
Aug 2, 24 Raymond James
Outperform
Jul 26, 24 Stifel
Buy
Jul 11, 24 Citigroup
Neutral
Jul 2, 24 Evercore ISI Group
Outperform
May 30, 24 Goldman Sachs
Buy
May 6, 24 Barclays
Overweight

Screeners with BDX included

US stocks
High Piotroski score stocks
S&P 500 companies earnings calendar
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 3 months
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar
Healthcare sector

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$228.00
BDX price is $228.00

Price All-time High

$283.59
BDX price is currently -19.60% below its historical high of $283.59

Price Analysts Target

$275.00
BDX price is currently -17.09% lower than the consensus analysts' forecast

Price Today Change

-1.53%
BDX price is down -1.53% today

Price YTD Change

+0.44%
BDX price is up +0.44% since January 1st

Price 3-Year Change

-14.31%
BDX price is down -14.31% over the past 3 years

Market cap

Market Cap

$65.47 B
BDX market capitalization is $65.47 billion

Market Cap 3-Year Change

-13.6%
BDX market capitalization is down -13.6% over the past 3 years

Market Cap All-time High

$82.27 B
BDX market capitalization is currently -20.43% below its historical high of $82.27 billion

Market Cap Sector Rank

97.64%
BDX market capitalization is higher than 97.64% of companies in Healthcare sector

Technical

Beta

0.22
BDX beta is 0.22

200-day SMA

$233.40
BDX price is currently -2.31% below its 200-day simple moving average

14-day RSI

46.03
BDX 14-day relative strength index is 46.03

30-day Relative Volume

0.81
BDX 30-day relative volume is 0.81

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.04
BDX last dividend was $1.04 per share, with an ex-dividend date of December 9, 2024

Next Dividend

$1.04
BDX has announced a dividend of $1.04 per share, with an ex-dividend date set for March 10, 2025

Dividend per share

Annual Dividend Per Share

$3.80
BDX annual dividend per share is $3.80

Annual Dividend Per Share Sector Rank

90.12%
BDX annual dividend per share is higher than 90.12% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+4.4%
BDX annual dividend per share is up +4.4% year-on-year

Annual Dividend Per Share 3-Year Change

+14.46%
BDX annual dividend per share is up +14.46% over the past 3 years

Dividend yield

Annual Dividend Yield

1.67%
BDX annual dividend yield is 1.67%

Annual Dividend Yield Sector Rank

45%
BDX annual dividend yield is higher than 45% of companies in Healthcare sector

Other

Annual Payout Ratio

64.52%
BDX annual payout ratio is 64.52%

Annual Dividends Paid

$1.10 B
BDX annual dividends paid is $1.10 billion

Annual FCF

$3.07 B
BDX annual free cash flow is $3.07 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$20.18 B
BDX annual revenue is $20.18 billion

Annual Revenue Analysts Estimate

$21.85 B
BDX annual revenue is currently -7.67% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+4.16%
BDX annual revenue is up +4.16% year-on-year

Annual Revenue Sector Rank

96.32%
BDX annual revenue is higher than 96.32% of companies in Healthcare sector

Profit

Annual Gross Profit

$9.15 B
BDX annual gross profit is $9.15 billion

Annual Gross Margin

45.36%
BDX annual gross profit margin is 45.36%

Annual Operating Profit

$2.88 B
BDX annual operating income is $2.88 billion

Annual Operating Margin

14.29%
BDX annual operating profit margin is 14.29%

Annual Net Income

$1.71 B
BDX annual net profit is $1.71 billion

Annual Net Margin

8.55%
BDX annual net profit margin is 8.55%

EPS

Annual EPS

$5.86
BDX annual earnings per share is $5.86

Annual EPS Analysts Estimate

$14.43
BDX annual earnings per share is currently -59.38% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+18.62%
BDX annual earnings per share is up +18.62% year-on-year

Annual EPS Sector Rank

96.67%
BDX annual earnings per share is higher than 96.67% of companies in Healthcare sector

ROA & ROE

Annual ROA

3.10%
BDX annual return on assets is 3.10%

Annual ROE

6.60%
BDX annual return on equity is 6.60%

EBIT & EBITDA

Annual EBIT

$2.56 B
BDX annual earnings before interest & taxes is $2.56 billion

Annual EBITDA

$4.85 B
BDX annual EBITDA is $4.85 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

37.87
BDX price to earnings ratio is 37.87

PE Ratio Sector Rank

66.84%
BDX price to earnings ratio is higher than 66.84% of companies in Healthcare sector

PB Ratio

PB Ratio

2.60
BDX price to book ratio is 2.60

PB Ratio Sector Rank

66.39%
BDX price to book ratio is higher than 66.39% of companies in Healthcare sector

PS Ratio

PS Ratio

3.17
BDX price to sales ratio is 3.17

PS Ratio Sector Rank

50.13%
BDX price to sales ratio is higher than 50.13% of companies in Healthcare sector

Enterprise value

Enterprise Value

$83.51 B
BDX enterprise value is $83.51 billion

Enterprise Value Sector Rank

98.51%
BDX enterprise value is higher than 98.51% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

17.19
BDX EV/EBITDA is 17.19

EV/EBITDA Sector Rank

89.36%
BDX EV/EBITDA is higher than 89.36% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.17
BDX annual current ratio is 1.17

Annual Quick Ratio

0.74
BDX annual quick ratio is 0.74

Leverage

Annual Debt To Equity

0.78
BDX annual debt to equity ratio is 0.78

Annual Interest Coverage Ratio

4.85
BDX annual interest coverage ratio is 4.85

Risk & Stability

Piotroski F-Score

7
BDX piotroski f-score is 7

Altman Z-Score

2.18
BDX altman z-score is 2.18

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$57.29 B
BDX annual total assets is $57.29 billion

Annual Non Current Assets

$46.82 B
BDX annual long term assets is $46.82 billion

Annual Current Assets

$10.47 B
BDX annual total current assets is $10.47 billion

Annual Cash & Cash Equivalents

$1.72 B
BDX annual cash & cash equivalents is $1.72 billion

Equity

Annual Book Value

$25.91 B
BDX annual book value is $25.91 billion

Annual Working Capital

$1.52 B
BDX annual working capital is $1.52 billion

Liabilities

Annual Total Liabilities

$31.40 B
BDX annual total liabilities is $31.40 billion

Annual Total Long Term Liabilities

$22.43 B
BDX annual total long term liabilities is $22.43 billion

Annual Current Liabilities

$8.95 B
BDX annual total current liabilities is $8.95 billion

Annual Accounts Payable

$1.90 B
BDX annual accounts payable is $1.90 billion

Debt

Annual Total Debt

$20.11 B
BDX annual total debt is $20.11 billion

Annual Total Debt 1-Year Change

+26.65%
BDX annual total debt is up +26.65% year-on-year

Annual Long Term Debt

$17.94 B
BDX annual long term debt is $17.94 billion

Annual Short Term Debt

$2.17 B
BDX annual short term debt is $2.17 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$17.29 B
BDX annual total expenses is $17.29 billion

Annual Operating Expenses

$6.27 B
BDX annual total operating expenses is $6.27 billion

Annual Cost Of Goods Sold

$11.03 B
BDX annual cost of goods sold is $11.03 billion

Annual SGA

$4.86 B
BDX annual SGA is $4.86 billion

Annual D&A

$2.29 B
BDX annual depreciation & amortization is $2.29 billion

Annual Interest Expense

$528.00 M
BDX annual interest expense is $528.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$3.80 B
BDX annual cash flow from operations is $3.80 billion

Annual CFO 1-Year Change

+27.03%
BDX annual cash flow from operations is up +27.03% year-on-year

Annual CFI

-$5.51 B
BDX annual cash flow from investing activities is -$5.51 billion

Annual CFI 1-Year Change

-670.11%
BDX annual cash flow from investing activities is down -670.11% year-on-year

Annual CFF

$2.09 B
BDX annual cash flow from financing activities is $2.09 billion

Annual CFF 1-Year Change

+206.59%
BDX annual cash flow from financing activities is up +206.59% year-on-year

Free CashFlow

Annual FCF

$3.07 B
BDX annual free cash flow is $3.07 billion

Annual FCF 1-Year Change

+45.25%
BDX annual free cash flow is up +45.25% year-on-year

CAPEX

Annual CAPEX

$725.00 M
BDX annual capital expenditures is $725.00 million

Annual CAPEX 1-Year Change

-17.05%
BDX annual capital expenditures is down -17.05% year-on-year

Institutional Ownership

Similar stocks

ZTS logo
Zoetis (ZTS)
GSK logo
GSK (GSK)
MCK logo
McKesson (MCK)
REGN logo
Regeneron Pharmaceuticals (REGN)
CVS logo
CVS Health (CVS)
HCA logo
HCA Healthcare (HCA)
TAK logo
Takeda Pharmaceutical Company Limited (TAK)
HLN logo
Haleon (HLN)
ALC logo
Alcon (ALC)

FAQ

  • What is the ticker symbol for Becton Dickinson and Company?
  • Does Becton Dickinson and Company pay dividends?
  • What sector is Becton Dickinson and Company in?
  • What industry is Becton Dickinson and Company in?
  • What country is Becton Dickinson and Company based in?
  • When did Becton Dickinson and Company go public?
  • Is Becton Dickinson and Company in the S&P 500?
  • Is Becton Dickinson and Company in the NASDAQ 100?
  • Is Becton Dickinson and Company in the Dow Jones?
  • When was Becton Dickinson and Company's last earnings report?
  • When does Becton Dickinson and Company report earnings?
  • Should I buy Becton Dickinson and Company stock now?

What is the ticker symbol for Becton Dickinson and Company?

The ticker symbol for Becton Dickinson and Company is NYSE:BDX

Does Becton Dickinson and Company pay dividends?

Yes, Becton Dickinson and Company pays dividends. The last payment was $1.04, with an ex-dividend date on December 9, 2024

What sector is Becton Dickinson and Company in?

Becton Dickinson and Company is in the Healthcare sector

What industry is Becton Dickinson and Company in?

Becton Dickinson and Company is in the Medical Instruments & Supplies industry

What country is Becton Dickinson and Company based in?

Becton Dickinson and Company is headquartered in United States

When did Becton Dickinson and Company go public?

Becton Dickinson and Company's initial public offering (IPO) was on February 21, 1973

Is Becton Dickinson and Company in the S&P 500?

Yes, Becton Dickinson and Company is included in the S&P 500 index

Is Becton Dickinson and Company in the NASDAQ 100?

No, Becton Dickinson and Company is not included in the NASDAQ 100 index

Is Becton Dickinson and Company in the Dow Jones?

No, Becton Dickinson and Company is not included in the Dow Jones index

When was Becton Dickinson and Company's last earnings report?

Becton Dickinson and Company's most recent earnings report was on Feb 6, 2025

When does Becton Dickinson and Company report earnings?

The next expected earnings date for Becton Dickinson and Company is May 1, 2025

Should I buy Becton Dickinson and Company stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions